Test Price
1,500 AED✅ Home Collection Available
PD-L1 SP142 Immunohistochemistry Test in UAE | 1500 AED | 2026 DHA Guidelines
تحليل PD-L1 SP142 المناعي في الإمارات | 1500 درهم | معتمد من هيئة الصحة بدبي
Clinical Excellence & Patient Assurance
- ✓Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified IHC Protocols, validated against international proficiency standards.
- ✓Premium Logistics: Hospital-Grade Home Collection with ISO-Certified Cold-Chain transport of FFPE blocks; VIP Mobile Phlebotomy service available.
- ✓Clinical Guidance: Complimentary Post-Test Telephonic Consultation with a DHA-Licensed Specialist to interpret your PD-L1 status and next steps.
- ✓Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731. We work with major UAE networks.
Test Overview
The PD-L1 SP142 Immunohistochemistry Test semi‑quantitatively measures programmed death‑ligand 1 expression on tumor cells and tumour‑infiltrating immune cells. This clone‑specific assay is pivotal for identifying patients who may benefit from atezolizumab (Tecentriq) immunotherapy, particularly in non‑small cell lung cancer, urothelial carcinoma, and triple‑negative breast cancer. نتائج هذا الفحص تُستخدم لتحديد مدى استجابة المريض للعلاج المناعي الموجه.
| Feature | Our Test (SP142 IHC) | Alternative (Standard IHC, 22C3/28-8) |
|---|---|---|
| Clinical Precision | Specifically validated for atezolizumab; dual scoring (TC & IC) | Primarily scored for pembrolizumab/nivolumab; single TC scoring |
| Methodology | Immunohistochemistry with SP142 antibody clone, ISO‑accredited | IHC using different clones (22C3, 28-8); variable lab accreditation |
| Report Turnaround | 5–7 working days (Faster for FFPE blocks) | Often 7–10 days |
DHA-Certified Physician Insight & Safety Protocol
A clinical note from Dr. PRABHAKAR REDDY, DHA License No. 61713011: “As a DHA-licensed oncologist, I understand the emotional weight carried by patients awaiting a biomarker result. This PD-L1 SP142 assay provides a critical piece of your personalized treatment puzzle, but it must be interpreted within the full clinical picture. I strongly recommend that you discuss these results with your treating oncologist before initiating or modifying any therapy.”
Medication Warning
Do not discontinue prescribed medication or alter your treatment plan without consulting your doctor.
Safety Exclusion Criteria & ER Red Flags
- Exclusion: Severe coagulopathy, active infection at the biopsy site, or inability to provide adequate tissue sample.
- Exclusion: Patients who cannot safely discontinue anticoagulants per physician instruction (if required for biopsy).
- ER Red Flag: Seek urgent medical attention if you experience fever >38°C, unrelenting pain, or pus/discharge at the biopsy site after the procedure.
- ER Red Flag: Rapid swelling or bleeding that does not stop with gentle pressure.
Patient FAQ & Clinical Guidance
Q: What is PD-L1 SP142 testing and why is it performed?
A: PD-L1 SP142 immunohistochemistry evaluates tumor PD-L1 expression to predict response to atezolizumab immunotherapy in advanced cancers. This provides a quantitative score (TC and IC) that oncologists use to determine eligibility for targeted treatment, improving the chance of a positive outcome.
ج: فحص PD-L1 SP142 بتقنية الكيمياء النسيجية المناعية يقيس تعبير البروتين PD-L1 في الخلايا السرطانية والخلايا المناعية لتحديد استجابة المريض لدواء أتيزوليزوماب المناعي، ويستخدم في تحديد العلاج الأنسب لسرطانات الرئة والمثانة والثدي الثلاثي السلبي.
Q: How should I prepare for the biopsy and sample submission?
A: No special patient preparation is needed, but you must arrange for a fresh tumor biopsy or FFPE block, provide a copy of your histopathology report, and note your biopsy site and relevant clinical history. Our home collection team will transport the sample under strict cold‑chain protocols.
ج: لا تحتاج إلى تحضيرات خاصة، لكن يجب توفير عينة الورم المحفوظة في الفورمالين أو القالب الشمعي، مع نسخة من تقرير الأنسجة المرضية وتفاصيل موقع الخزعة والتاريخ السريري. فريقنا المتنقل يتولى النقل وفق شروط التبريد المعتمدة.
Q: When will I receive my results and who will explain them?
A: Routine FFPE block reports are ready in 5 working days; large complex specimens take up to 7 days. A complimentary telephonic consultation with a DHA-licensed pathologist or oncologist is included to guide you through the PD-L1 scoring and its therapeutic implications.
ج: تظهر النتائج خلال 5 أيام عمل للعينات المحفوظة بالشمع، و7 أيام للعينات الكبيرة المعقدة. ستتلقى استشارة هاتفية مجانية مع أخصائي حاصل على ترخيص هيئة الصحة بدبي لشرح النتيجة وتأثيرها على خطة العلاج.
UAE Regulatory Compliance: This service operates under Federal Decree-Law No. 41 of 2024 on Health Professions (Art. 87) and the 2026 CDS Law governing minor’s testing. All patient data is handled in strict adherence to the UAE Personal Data Protection Law (PDPL). Facility License No. 9834453.
ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139)
For insurance verification or home collection booking, WhatsApp +971 54 548 8731 (8 AM – 11 PM daily).
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians